Srikripa Devarakonda
Stock Analyst at Truist Securities
(0.68)
# 2437
Out of 5,370 analysts
70
Total ratings
36.96%
Success rate
1.52%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
INCY Incyte | Maintains: Hold | 72 73 | 71.13 | 2.63% | 10 | May 27, 2025 | |
ARVN Arvinas | Downgrades: Hold | 21 11 | 7.38 | 49.05% | 1 | May 5, 2025 | |
REGN Regeneron Pharmaceut... | Maintains: Buy | 975 940 | 522.29 | 79.98% | 7 | Apr 30, 2025 | |
BIIB Biogen | Maintains: Buy | 210 199 | 131.07 | 51.83% | 4 | Apr 29, 2025 | |
KROS Keros Therapeutics | Maintains: Buy | 43 25 | 13.63 | 83.42% | 5 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 60 76 | 54.66 | 39.04% | 2 | Mar 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 1029 1038 | 807.13 | 28.6% | 4 | Feb 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 211 217 | 190.7 | 13.79% | 3 | Feb 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 32 | 24.39 | 31.2% | 1 | Dec 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 33 50 | 14.66 | 241.06% | 6 | Nov 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 36 45 | 32.15 | 39.97% | 4 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 54 53 | 46.85 | 13.13% | 3 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 54 54 | 2.65 | 1937.74% | 1 | Sep 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 15 | 5.62 | 166.9% | 7 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 36 | 11.87 | 203.29% | 1 | Jul 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 70 | 33.75 | 107.41% | 4 | May 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 60 | n/a | n/a | 2 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 38 | n/a | n/a | 3 | Mar 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 50 34 | n/a | n/a | 2 | Jun 3, 2021 |